ImmunityBio, Inc. (IBRX)
7.575
-0.22
(-2.76%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
-0.06
(-0.73%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly) : -1.047B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.047B |
| March 31, 2026 | -870.01M |
| December 31, 2025 | -500.47M |
| September 30, 2025 | -524.32M |
| June 30, 2025 | -570.75M |
| March 31, 2025 | -591.43M |
| December 31, 2024 | -489.10M |
| September 30, 2024 | -745.15M |
| June 30, 2024 | -698.39M |
| March 31, 2024 | -692.01M |
| December 31, 2023 | -586.99M |
| September 30, 2023 | -411.72M |
| June 30, 2023 | -642.12M |
| March 31, 2023 | -528.98M |
| December 31, 2022 | -447.33M |
| September 30, 2022 | -426.70M |
| June 30, 2022 | -419.82M |
| March 31, 2022 | -335.64M |
| December 31, 2021 | -242.17M |
| September 30, 2021 | -188.50M |
| June 30, 2021 | -157.94M |
| March 31, 2021 | -185.79M |
| December 31, 2020 | 117.39M |
| September 30, 2020 | 148.62M |
| Date | Value |
|---|---|
| June 30, 2020 | 169.65M |
| March 31, 2020 | 102.60M |
| December 31, 2019 | 120.68M |
| September 30, 2019 | 135.96M |
| June 30, 2019 | 151.27M |
| March 31, 2019 | 167.81M |
| December 31, 2018 | 146.01M |
| September 30, 2018 | 162.09M |
| June 30, 2018 | 181.63M |
| March 31, 2018 | 200.36M |
| December 31, 2017 | 218.84M |
| September 30, 2017 | 237.70M |
| June 30, 2017 | 252.92M |
| March 31, 2017 | 278.37M |
| December 31, 2016 | 293.42M |
| September 30, 2016 | 310.89M |
| June 30, 2016 | 327.36M |
| March 31, 2016 | 344.50M |
| December 31, 2015 | 356.00M |
| September 30, 2015 | 362.93M |
| June 30, 2015 | 126.52M |
| March 31, 2015 | 49.08M |
| December 31, 2014 | 57.59M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.528B |
| Cogent Biosciences, Inc. | 532.39M |
| Moderna, Inc. | 6.761B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 628.50M |
| Total Liabilities (Quarterly) | 1.674B |
| Debt to Equity Ratio | -1.174 |
| Current Ratio | 5.721 |
| Net Debt Paydown Yield | -0.88% |